Research To Prevent Blindness Organization Awards $60,000 To Lu
Main Category: Eye Health / BlindnessArticle Date: 16 Jul 2010 - 5:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
4.5 (2 votes) |
Qingxian Lu, PhD, assistant professor of ophthalmology and visual sciences at the University of Louisville School of Medicine, has received the $60,000 William and Mary Greve Special Scholar Award from the Research to Prevent Blindness (RPB) organization. The funds will go toward Lu's research in retinitis pigmentosa, a group of genetic disorders that can lead to night blindness, loss of peripheral vision and total blindness.
Lu's research focuses specifically on a cellular receptor called MerTK, which may play a role in limiting the duration of immune response, leading to the development of retinal inflammation. Understanding this mechanism of action may lead to better prevention and treatment techniques in the future.
Retinitis pigmentosa is a group of inherited disorders caused by molecular defects in more than 100 different genes. Navajo Indians are the ethnic group most affected by it.
"The RPB Special Scholar Award will significantly accelerate our ongoing research programs and secure a continuous investigation of the cellular activity related to the development of the retinal autoimmunity that occurs in retinitis pigmentosa," Lu said.
The William and Mary Greve Special Scholar Award is aimed at supporting research into the causes, treatment and prevention of blinding diseases. The award is part of RPB's Special Scholar Program designed to support outstanding young scientists who are conducting research of unusual significance and promise.
Source:
Lauren Williams
University of Louisville
Visit our eye health / blindness section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/194861.php>
APA
http://www.medicalnewstoday.com/releases/194861.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





